David Crean

David H.
Crean is the founder of Cardiff Advisory LLC, founded in 2021, where the title held is Managing Partner.
Current jobs include President & Chief Executive Officer at Coast Bioventures LLC; Chairman & President at Alzheimer's Association Northern California & Northern Nevada; Director at Association for Corporate Growth of Orange County; Independent Director at Paracrine, Inc. since 2022; Director at Almon Therapeutics, Inc.; Director at Cenna Biosciences, Inc. since 2023; Director at Biocom California since 2022; Chief Business Officer at MediciNova, Inc. since 2021; Member at Securities Investor Protection Corp.; Member at Corporate Directors Forum; Member at Financial Industry Regulatory Authority, Inc.; Partner at Mesa Verde Venture Partners LP; and Venture Partner at VU Venture Partners since 2024.
Former jobs include Chief Executive Officer & Director at Talapo Therapeutics, Inc. from 2018 to 2020; President & Chief Executive Officer at Boys & Girls Clubs of San Dieguito from 2013 to 2015; Director at Histogen, Inc. from 2018 to 2020; Director at Phoenix Molecular Designs Ltd. from 2021 to 2022; Managing Director at Objective Capital Partners LLC from 2015 to 2022; Director at California Life Sciences Association from 2018 to 2024; Independent Director at Histogen, Inc. from 2023 to 2024; Vice President-Corporate Development at Almirall LLC; and Member-Governors Board at Biocom, Inc. Education includes undergraduate degree from Canisius College; graduate and doctorate degrees from State University of New York at Buffalo; and MBAistration from Pepperdine Graziadio Business School.